Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Martínez-Moragón E[au]:

Asthma, rhinitis, and nasal polyp multimorbidities. Castillo Vizuete JA et al. Arch Bronconeumol. (2019)

Management of asthma in the emergency department: a consensus statement. Piñera Salmerón P et al. Emergencias. (2018)

Guidelines for severe uncontrolled asthma. Cisneros Serrano C et al. Arch Bronconeumol. (2015)

Search results

Items: 1 to 50 of 81

1.

Asthma, comorbidities, and aggravating circumstances. The GEMA-FORUM II task force.

Trigueros JA, Plaza V, Domínguez Ortega J, Serrano J, Cisneros C, Padilla A, Antón Gironés M, Mosteiro M, Martínez Moragón E, Olaguíbel Rivera JM, Delgado J, García Rivero JL, Martínez Rivera C, Garrido JJ, Quirce S; GEMAFORUM task force.

J Investig Allergol Clin Immunol. 2019 Oct 10:0. doi: 10.18176/jiaci.0460. [Epub ahead of print] No abstract available.

PMID:
31599723
2.

Factors that determine the loss of control when reducing therapy by steps in the treatment of moderate-severe asthma in standard clinical practice: A multicentre Spanish study.

Martínez-Moragón E, Delgado J, Mogrovejo S, Fernández-Sánchez T; en nombre del grupo de investigación STEP; Anexo.

Rev Clin Esp. 2019 Jul 23. pii: S0014-2565(19)30150-X. doi: 10.1016/j.rce.2019.05.004. [Epub ahead of print] English, Spanish.

PMID:
31350049
3.

Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice.

Martínez-Moragón E, Climent M, Chiner E, Fernández-Aracil C, Sánchez-Toril F, Lluch-Tortajada I.

Farm Hosp. 2019 May 1;43(3):101-109. doi: 10.7399/fh.11167.

4.

Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.

Pérez de Llano L, Martínez-Moragón E, Plaza Moral V, Trisan Alonso A, Sánchez CA, Callejas FJ, Vera E, Soto Campos JG, Martinez Rivera C, Alcázar Navarrete B, Urrutia Landa I, Garcia Rivero JL, Padilla Galo A, Alvarez Gutierrez F, Landete P, Ramos González J, Aracil CF, Carretero Gracia JÁ, Lluch I, Puente L, Andujar-Espinosa R, Cosío BG.

Respir Med. 2019 May;151:49-54. doi: 10.1016/j.rmed.2019.03.006. Epub 2019 Apr 1. No abstract available.

PMID:
31047117
5.

Pneumonia in Asthma Patients: Are We Giving It Enough Attention?

Cabanes L, Valentín V, Martinez Moragón E.

Arch Bronconeumol. 2019 Jul;55(7):397-398. doi: 10.1016/j.arbres.2018.12.013. Epub 2019 Apr 7. English, Spanish. No abstract available.

6.

Cost-effectiveness of the withdrawl of treatment with inhaled colistin in patients with adult bronchiectasis not due to cystic fibrosis colonized by Pseudomonas aeruginosa.

Lera Álvarez R, Martínez Moragón E, Morales Suárez Varela M.

Med Clin (Barc). 2018 Dec 26. pii: S0025-7753(18)30725-5. doi: 10.1016/j.medcli.2018.11.008. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
30594304
7.

Asthma, rhinitis, and nasal polyp multimorbidities.

Castillo Vizuete JA, Sastre J, Del Cuvillo Bernal A, Picado C, Martínez Moragón E, Ignacio García JM, Cisneros Serrano C, Álvarez Gutiérrez FJ, Mullol Miret J.

Arch Bronconeumol. 2019 Mar;55(3):146-155. doi: 10.1016/j.arbres.2018.09.001. Epub 2018 Nov 16. English, Spanish.

8.

A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy.

Pérez de Llano L, García-Rivero JL, Urrutia I, Martínez-Moragón E, Ramos J, Cebollero P, Carballada F, Blanco-Aparicio M, Vennera MDC, Merino M, Torralba-García Y, Plaza V.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1214-1221.e3. doi: 10.1016/j.jaip.2018.10.017. Epub 2018 Oct 25.

PMID:
30368006
9.

Management of asthma in the emergency department: a consensus statement.

Piñera Salmerón P, Delgado Romero J, Domínguez Ortega J, Labrador Horrillo M, Álvarez Gutiérrez FJ, Martínez Moragón E, Plaza Moral V, Álvarez Rodríguez C, Miguel Franco J.

Emergencias. 2018 Ago;30(4):268-277. English, Spanish.

10.

Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

de Llano LP, Cosío BG, Iglesias A, de Las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez-Moragon E, Soriano JB, Viña AL, Bobolea I.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 12;13:591-601. doi: 10.2147/COPD.S153694. eCollection 2018.

11.

Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient.

Cabanes L, Plaza P, Martinez Moragón E.

Med Clin (Barc). 2018 Jun 8;150(11):451. doi: 10.1016/j.medcli.2017.10.018. Epub 2017 Nov 26. English, Spanish. No abstract available.

PMID:
29179893
12.

Algorithm for the management of asthma in pregnant women: a protocol to optimize processes in healthcare.

Martinez-Moragón E, Romero-Falcón A, García-Rivero JL.

Expert Rev Respir Med. 2017 Dec;11(12):1003-1012. doi: 10.1080/17476348.2017.1391094. Epub 2017 Oct 23.

PMID:
29016232
13.

Fibromyalgia as a cause of uncontrolled asthma: a case-control multicenter study.

Martinez-Moragon E, Plaza V, Torres I, Rosado A, Urrutia I, Casas X, Hinojosa B, Blanco-Aparicio M, Delgado J, Quirce S, Sabadell C, Cebollero P, Muñoz-Fernández A.

Curr Med Res Opin. 2017 Dec;33(12):2181-2186. doi: 10.1080/03007995.2017.1354828. Epub 2017 Aug 11.

PMID:
28699806
14.

Pulmonary Thromboembolism as a First Manifestation of Atrial Myxoma.

Climent M, Furest I, Martínez Moragón E.

Arch Bronconeumol. 2018 Jan;54(1):46-47. doi: 10.1016/j.arbres.2017.05.020. Epub 2017 Jul 3. English, Spanish. No abstract available.

15.

Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry.

De la Rosa D, Martínez-Garcia MA, Giron RM, Vendrell M, Olveira C, Borderias L, Maiz L, Torres A, Martinez-Moragon E, Rajas O, Casas F, Cordovilla R, de Gracia J.

PLoS One. 2017 May 18;12(5):e0177931. doi: 10.1371/journal.pone.0177931. eCollection 2017.

16.

Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?

Cosío BG, Pérez de Llano L, Lopez Viña A, Torrego A, Lopez-Campos JL, Soriano JB, Martinez Moragon E, Izquierdo JL, Bobolea I, Callejas J, Plaza V, Miravitlles M, Soler-Catalunya JJ; on behalf of the CHACOS study group.

Eur Respir J. 2017 May 1;49(5). pii: 1602397. doi: 10.1183/13993003.02397-2016. Print 2017 May.

17.

Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis.

Girón RM, de Gracia Roldán J, Olveira C, Vendrell M, Martínez-García MÁ, de la Rosa D, Máiz L, Ancochea J, Vázquez L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Soriano JB.

Chron Respir Dis. 2017 Nov;14(4):360-369. doi: 10.1177/1479972317702139. Epub 2017 Apr 10.

18.

Quality Indicators of Asthma Care Derived From the Spanish Guidelines for Asthma Management (GEMA 4.0): A Multidisciplinary Team Report.

Quirce S, Delgado J, Entrenas LM, Grande M, Llorente C, López Viña A, Martínez Moragón E, Mascarós E, Molina J, Olaguibel JM, Pérez de Llano LA, Perpiñá Tordera M, Quintano JA, Rodríguez M, Román-Rodriguez M, Sastre J, Trigueros JA, Valero AL, Zoni AC, Plaza V; ASMAFORUM II Group.

J Investig Allergol Clin Immunol. 2017;27(1):69-73. doi: 10.18176/jiaci.0121. No abstract available.

19.

Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry.

Olveira C, Padilla A, Martínez-García MÁ, de la Rosa D, Girón RM, Vendrell M, Máiz L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Casas F, Cordovilla R, de Gracia J.

Arch Bronconeumol. 2017 Jul;53(7):366-374. doi: 10.1016/j.arbres.2016.12.003. Epub 2017 Jan 21. English, Spanish.

20.

Bronchomalacia in adults: an infrequent entity that improves with continuous positive pressure on the airway

Cepeda S, Climent M, Martínez Moragón E.

An Sist Sanit Navar. 2016 Dec 30;39(3):457-458. doi: 10.23938/ASSN.0230. Spanish. No abstract available.

21.

Multidisciplinary expert discussion. Uncontrolled asthma: causes, consequences and possible solutions

Plaza V, Quirce S, Delgado J, Martinez Moragón E, Pérez de Llano L; Grupo multidisciplinar de expertos "Asmaforum".

An Sist Sanit Navar. 2016 Nov 21;39(3):357-370. doi: 10.23938/ASSN.0233. Spanish.

22.

Excessive variability in the performance and interpretation of the metacholine bronchial challenge test.

Martínez Moragón E, Pérez de Llano L, Perpiñá M.

Arch Bronconeumol. 2016 Nov;52(11):574. doi: 10.1016/j.arbres.2016.05.001. Epub 2016 Jun 16. English, Spanish. No abstract available.

23.

Management and referral of patients with severe and poorly controlled asthma in primary care.

Orozco-Beltrán D, Carratalá-Munuera C, Arriero JM, Campo P, Martínez-Moragón E, Molina J, Quintano-Jiménez JA, Gil-Guillén VF; Working Group for the Consensus Document on the Management of Severe Asthma in Adults in Primary Health Care.

Fam Pract. 2016 Dec;33(6):678-683. Epub 2016 Aug 20.

PMID:
27543792
24.

Attitudes and barriers uncontrolled asthma in Spain. Abanico study.

Martinez-Moragon E, Entrenas LM, Plaza V, Quirce S.

Rev Clin Esp. 2017 Jan - Feb;217(1):60-62. doi: 10.1016/j.rce.2016.06.008. Epub 2016 Jul 30. English, Spanish. No abstract available.

PMID:
27484344
25.

Ocular Hypertension Requiring Suspension of Inhaled Corticosteroids.

Mogrovejo S, Martínez Moragón E, Climent M.

Arch Bronconeumol. 2017 Jan;53(1):34. doi: 10.1016/j.arbres.2016.06.002. Epub 2016 Jul 2. English, Spanish. No abstract available.

26.

What pulmonologists think about the asthma-COPD overlap syndrome.

Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015.

27.

Incidence and Triggers of Asthma Exacerbations Attended in the Emergency Department as a Level of Care Indicator (ASMAB III, 2005 and ASMAB IV, 2011).

Ojanguren I, Genover T, Muñoz X, Ramon MA, Martínez Moragon E, Morell F.

Arch Bronconeumol. 2016 Feb;52(2):82-7. doi: 10.1016/j.arbres.2015.02.007. Epub 2015 Apr 22. English, Spanish.

28.

Guidelines for severe uncontrolled asthma.

Cisneros Serrano C, Melero Moreno C, Almonacid Sánchez C, Perpiñá Tordera M, Picado Valles C, Martínez Moragón E, Pérez de Llano L, Soto Campos JG, Urrutia Landa I, García Hernández G.

Arch Bronconeumol. 2015 May;51(5):235-46. doi: 10.1016/j.arbres.2014.12.007. Epub 2015 Feb 10. English, Spanish.

29.

Pertussis in Adults: A Growing Diagnosis in the Pulmonology Clinic.

Cepeda S, Martínez Moragón E, Ponce S.

Arch Bronconeumol. 2015 Sep;51(9):472-3. doi: 10.1016/j.arbres.2014.10.008. Epub 2014 Dec 22. English, Spanish. No abstract available.

30.

An asthmatic patient with bronchomalacia and good response with continuous positive airway pressure.

Sala A, Martínez Deltoro A, Martínez Moragón E.

Arch Bronconeumol. 2014 May;50(5):207-8. doi: 10.1016/j.arbres.2013.09.003. Epub 2013 Oct 15. English, Spanish. No abstract available.

31.

Factors affecting quality of life of asthma patients in Spain: the importance of patient education.

Martínez-Moragón E, Palop M, de Diego A, Serra J, Pellicer C, Casán P, Caloto MT, Nocea G; ASMACOST Study Group.

Allergol Immunopathol (Madr). 2014 Sep-Oct;42(5):476-84. doi: 10.1016/j.aller.2013.06.006. Epub 2013 Oct 2.

PMID:
24094444
32.

Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.

Diego AD, Milara J, Martinez-Moragón E, Palop M, León M, Cortijo J.

Respirology. 2013 Oct;18(7):1056-62. doi: 10.1111/resp.12130.

PMID:
23714268
33.

Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry.

de Llano LP, Vennera Mdel C, Álvarez FJ, Medina JF, Borderías L, Pellicer C, González H, Gullón JA, Martínez-Moragón E, Sabadell C, Zamarro S, Picado C; Spanish Registry.

J Asthma. 2013 Apr;50(3):296-301. doi: 10.3109/02770903.2012.757780. Epub 2013 Jan 28. Erratum in: J Asthma. 2013 Jun;50(5):537-9.

PMID:
23350994
34.

Interstitial pneumonitis secondary to eprosartan.

Pérez-Lluna L, Martinez-Moragón E, Fullana-Monllor J.

Arch Bronconeumol. 2012 Dec;48(12):485. doi: 10.1016/j.arbres.2012.06.004. Epub 2012 Jul 31. English, Spanish. No abstract available.

35.

Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches.

Vennera Mdel C, Pérez De Llano L, Bardagí S, Ausin P, Sanjuas C, González H, Gullón JA, Martínez-Moragón E, Carretero JA, Vera E, Medina JF, Alvarez FJ, Entrenas LM, Padilla A, Irigaray R, Picado C; Spanish Registry.

J Asthma. 2012 May;49(4):416-22. doi: 10.3109/02770903.2012.668255. Epub 2012 Mar 23.

PMID:
22443408
36.

[Asthma control: a distant objective].

Martínez Moragón E.

Arch Bronconeumol. 2010 Jul;46(7):347-8. doi: 10.1016/j.arbres.2010.03.009. Epub 2010 May 10. Spanish. No abstract available.

37.

[Inflammation markers in the exhaled air of patients with bronchiectasis unassociated with cystic fibrosis].

Palop-Cervera M, de Diego Damiá A, Martínez-Moragón E, Cortijo J, Fullana J, León M.

Arch Bronconeumol. 2009 Dec;45(12):597-602. doi: 10.1016/j.arbres.2009.09.007. Epub 2009 Oct 28. Spanish.

38.

[Economic cost of treating the patient with asthma in Spain: the AsmaCost study].

Martínez-Moragón E, Serra-Batllés J, De Diego A, Palop M, Casan P, Rubio-Terrés C, Pellicer C; por el Grupo de Investigadores del estudio AsmaCost.

Arch Bronconeumol. 2009 Oct;45(10):481-6. doi: 10.1016/j.arbres.2009.04.006. Epub 2009 Jun 13. Spanish.

39.

[Spanish asthma patients' beliefs about health and medicines: validation of 2 questionnaires].

Perpiñá Tordera M, Martínez Moragón E, Belloch Fuster A, Lloris Bayo A, Pellicer Císcar C.

Arch Bronconeumol. 2009 May;45(5):218-23. doi: 10.1016/j.arbres.2008.06.006. Epub 2009 Apr 16. Spanish.

40.

[Perception of dyspnea and treatment adherence in asthmatic patients].

Martínez-Moragón E, Perpiñá M, Fullana J, Macián V, Lloris A, Belloch A.

Arch Bronconeumol. 2008 Sep;44(9):459-63. Spanish.

41.

[Impact of baseline and induced dyspnea on the quality of life of patients with COPD].

Martínez Francés ME, Perpiñá Tordera M, Belloch Fuster A, Martínez Moragón EM, Compte Torrero L.

Arch Bronconeumol. 2008 Mar;44(3):127-34. Spanish.

42.

[Pneumonia in the elderly population over 70 years with limited functional condition: case-control study of institutionalized patients].

Serra Sanchis B, Martínez Moragón E, Aguar M, Fernández Fabrellas E, Sanz F, Blanquer J; Grupo de Neumonía Adquirida en la Comunidad de la Comunidad Valenciana.

Rev Clin Esp. 2007 Dec;207(11):548-54. Spanish.

PMID:
18021642
43.

Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.

Reyes Calzada S, Martínez Tomas R, Cremades Romero MJ, Martínez Moragón E, Soler Cataluña JJ, Menéndez Villanueva R.

Respir Med. 2007 Sep;101(9):1909-15. Epub 2007 Jul 12.

44.

[New highlight of acute interstitial pneumonia].

Fernández Fabrellas E, Domingo Montañana ML, Martínez Moragón E.

Rev Clin Esp. 2007 Jun;207(6):295-7. Spanish.

PMID:
17568518
45.

[Is the incidence of near-fatal asthma decreasing in Spain?].

Bellido Casado J, Plaza V, Bardagí S, Cosano J, López Viña A, Martínez Moragón E, Rodríguez-Trigo G, Picado C, Sanchis J.

Arch Bronconeumol. 2006 Oct;42(10):522-5. Spanish.

46.

[Does experience influence perception of dyspnea?].

Martínez-Moragón E, Perpiñá M, Belloch A.

Arch Bronconeumol. 2006 Apr;42(4):171-4. Spanish.

47.

[Evolution over time in over perceivers of dyspnea in asthma].

Martínez-Moragón E, Perpiñá M, Belloch A, Serra B, Lloris A, Macián V.

Arch Bronconeumol. 2006 Mar;42(3):120-4. Spanish.

48.

[Scientific impact of the Asthma Awareness Year, 2003: analysis of publications in Archivos de Bronconeumología].

de Diego-Damia A, Martínez-Moragón E.

Arch Bronconeumol. 2005 Dec;41(12):679-85. Review. Spanish. No abstract available.

49.

[Guidelines for the diagnosis and management of difficult-to-control asthma].

López-Viña A, Agüero-Balbín R, Aller-Alvarez JL, Bazús-González T, Cosio BG, de Diego-Damiá A, Martínez-Moragón E, Pereira-Vega A, Plaza-Moral V, Rodríguez-Trigo G, Villa-Asensi JR; Area de Asma-SEPAR.

Arch Bronconeumol. 2005 Sep;41(9):513-23. Spanish. No abstract available. Erratum in: Arch Bronconeumol. 2005 Nov;41(11):643. García-Cosio, FB [corrected to Cosio, BG].

50.

[Agreement in asthmatics' perception of dyspnea during acute and chronic obstruction].

Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés ME.

Arch Bronconeumol. 2005 Jul;41(7):371-5. Spanish.

Supplemental Content

Loading ...
Support Center